DeCode Files For Ch. 11 With Plan To Sell Assets

Law360, New York (November 17, 2009, 6:39 PM EST) -- Following 13 years of failing to make a profit on its research and development activities, Iceland-based genetic research company deCode Genetics Inc. has filed for Chapter 11 protection with a plan to sell its assets to Saga Investments LLC.

The company filed its petition Monday in the U.S. Bankruptcy Court for the District of Delaware, along with a plan to sell its Icelandic subsidiary Islensk Erfdagreining and drug discovery and development programs to Saga.

IE conducts deCode's human genetics research; manages its population genetics resources; and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.